Beijing Scitop Bio-tech Co., Ltd. Class ASZSE: 300858

Beijing Scitop Bio-tech Co: Revenue up, net profit slightly down, with improved cash flow and higher management expenses

· Issued by Beijing Scitop Bio-tech Co., Ltd. Class A

Revenue grew modestly year-over-year, while net profit declined slightly for the nine months. Cash flow improved, but investment income and EPS were flat; management expenses rose due to one-off factors.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Beijing Scitop Bio-tech Co., Ltd. Class A

All Beijing Scitop Bio-tech Co., Ltd. Class A news releases